Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
Merida Biosciences has raised $121.0M in total funding. The most recent round was Series A. The last funding was announced in April 2025.
Merida Biosciences's investors include Perceptive Advisors, Bain Capital Life Sciences, Third Rock Ventures, Google Ventures, Biotechnology Value Fund.
Merida Biosciences is headquartered in Cambridge, United States.
Merida Biosciences is a biotech company focused on developing precision treatments, particularly for autoimmune diseases.
Merida Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Merida Biosciences — Funding & Investors." VCBacked, April 8, 2025, https://www.vcbacked.co/company/merida-biosciences. Accessed July 19, 2026.
VCBacked. (2025). Merida Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/merida-biosciences
{{cite web |title=Merida Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/merida-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated